Loading...

APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  4. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  5. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  6. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  9. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  10. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  11. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  12. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  13. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  14. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  15. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  16. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  17. Page N, et al. 2018. Immunity. 48:937. PubMed
  18. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  19. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  20. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  21. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  22. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  23. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  24. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  25. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  26. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  27. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  28. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  29. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  30. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  31. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  32. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  33. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  34. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  35. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  36. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  37. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  38. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  39. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  40. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  41. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  42. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  43. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  44. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  45. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  46. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  47. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  48. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  49. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  50. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  51. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  52. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  53. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  54. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  55. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  56. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  57. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  58. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  59. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  60. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  61. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  62. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  65. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  66. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  67. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  68. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  69. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  70. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  71. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  72. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  73. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  74. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  75. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  76. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  77. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  78. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  79. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  80. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  81. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  82. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  83. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  84. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  85. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  86. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  87. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  88. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  89. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  90. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  91. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  92. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  93. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  94. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  95. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  96. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  97. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  98. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  99. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  100. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  101. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  102. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  103. Li N, et al. 2021. eLife. 10:00. PubMed
  104. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  105. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  106. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  107. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  108. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  109. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  110. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  111. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  112. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  113. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  114. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  115. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  116. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  117. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  118. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  119. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  120. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  121. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  122. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  123. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  124. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  125. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  126. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  127. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  128. White C, et al. 2015. J Immunol. 194:697. PubMed
  129. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  130. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  131. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  132. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  133. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  134. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  135. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  136. He J, et al. 2019. J Clin Invest. 130. PubMed
  137. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  138. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  139. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  140. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  141. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  142. Kim S, et al. 2021. Elife. 10:. PubMed
  143. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  144. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  145. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  146. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  147. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  148. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  149. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  150. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  151. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  152. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  153. Lang V, et al. 2021. Elife. 10:. PubMed
  154. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  155. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  156. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  157. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  158. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  159. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  160. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  161. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  162. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  163. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  164. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  165. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  166. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  167. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  168. Zhao L, et al. 2021. STAR Protocols. 2(3):100732. PubMed
  169. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  170. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  171. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  172. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  173. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  174. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  175. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  176. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  177. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  178. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  179. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  180. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  181. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  182. Li C, et al. 2018. Cell. 174:285. PubMed
  183. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  184. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  185. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  186. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  187. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  188. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  189. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  190. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  191. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  192. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  193. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  194. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  195. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  196. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  197. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  198. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  199. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  200. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  201. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  202. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  203. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  204. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  205. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  206. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  207. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  208. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  209. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  210. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  211. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  212. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  213. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  214. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  215. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  216. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  217. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  218. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  219. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  220. Smith LK, et al. 2021. Elife. 10:. PubMed
  221. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  222. Li H, et al. 2022. iScience. 25:104481. PubMed
  223. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  224. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  225. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  226. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  227. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  228. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  229. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  230. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  231. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  232. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  233. Zhang B, et al. 2021. Nature. 599:471. PubMed
  234. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  235. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  236. Gawish R, et al. 2022. Elife. 11:. PubMed
  237. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  238. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  239. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  240. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  241. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  242. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  243. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  244. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  245. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  246. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  247. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  248. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account